Certificate under 74(5) of SEBI (DP) Regulations , 2018 for the quarter ended September 30, 2025.
08 Oct, 2025 | 12:42pm • Source: BSE
Closure of Trading Window for the quarter and half-year ended FY 2025-26.
29 Sep, 2025 | 12:59pm • Source: BSE
Scrutinizer''s Report and Voting Results of 4th AGM of Valiant Laboratories Limited.
26 Sep, 2025 | 03:38pm • Source: BSE
Change in management.
25 Sep, 2025 | 05:47pm • Source: BSE
Proceedings of 4th AGM of Valiant Laboratories limited held through VC/OAVM.
25 Sep, 2025 | 05:39pm • Source: BSE
Newspaper Advertisement regarding Completion of Dispatch of Annual Report for FY 2024-25 and Notice of 4th Annual General Meeting to the members of the...
03 Sep, 2025 | 03:12pm • Source: BSE
Letter to shareholders under Regulation 36(1)(b) of SEBI (LODR) Regulations, 2015
01 Sep, 2025 | 08:47pm • Source: BSE
Notice and Annual Report of 4th AGM
01 Sep, 2025 | 08:37pm • Source: BSE
Valiant Laboratories Limited has informed the Exchange about Copy of Newspaper Publication
28 Aug, 2025 | 12:34pm • Source: NSE
Newspaper Advertisement - 4th AGM of the Company
28 Aug, 2025 | 12:23pm • Source: BSE
Newspaper publication regarding basis of allotment of Equity Shares under Rights Issue of the Company
13 Aug, 2025 | 04:54pm • Source: BSE
Allotment of Equity Shares on Rights Basis.
11 Aug, 2025 | 05:53pm • Source: BSE
Copy of Newspaper Publication for Financial Results of Q1 FY 2025-26
09 Aug, 2025 | 08:00pm • Source: BSE
Change in Designation of Director.
08 Aug, 2025 | 05:09pm • Source: BSE
Appointment of Secretarial Auditor.
08 Aug, 2025 | 05:04pm • Source: BSE
Outcome of Board Meeting dated August 08, 2025- Financial Results For Quarter Ended June 30, 2025
08 Aug, 2025 | 04:49pm • Source: BSE
Outcome of Board Meeting Dated August 08, 2025 - Financial Results for quarter ended June 30, 2025.
08 Aug, 2025 | 04:43pm • Source: BSE